Ultimate Products Share Discussion Threads

[toffeeman] 09/12/2024 18:45

Well if that's the case wait until it breaks back through 120 before buying.

[advfnagain] 09/12/2024 16:39

Looks like its breaking upwards out of the existing trading range

[toffeeman] 08/12/2024 10:36

I think it may drop to 90 which looks like decent support level, bwtfdik

[advfnagain] 06/12/2024 21:57

Leave a nice big stop loss so the market doesn't steal your juicy price .

[advfnagain] 06/12/2024 21:56

This is now just a case of not if but when it turns . I suspect next week will be the turning point.

[dr biotech] 06/12/2024 13:15

They forecast for 15p EPS. Market clearly thinks that would be a stretch. It’s a bargain if they are to achieve that.

[advfnagain] 06/12/2024 13:15

Understandable I suppose , maybe this is being priced in now . The outlook for fy25 seems under looked .. the order book for FY25, at this early stage, is significantly ahead of FY24.

[wjccghcc] 06/12/2024 12:30

I suspect potential buyers are waiting for the probable profit warning after the weak Q1.

[advfnagain] 06/12/2024 12:22

Just bought 3500 of these . They seem like a really good price with great future growth potential. I know the last report wasn't that great but forward looking things will get better . The house price index at an all time high will slowly start to increase consumer spending along with the Heavy Christmas spending . I am missing something here ?

[robbnw] 04/12/2024 08:57

Got my highest holding now and I'm sticking with it

[robbnw] 04/12/2024 08:52

Just bought 19000

[robbnw] 03/12/2024 10:10

Stay positiveThis will passA v good businessV well run

[epo001] 12/11/2024 15:05

Can Trump really be an issue here? There isn't much (any?) US trade for ULTP and US tariffs could result in price decreases across the rest of the world just to keep stuff moving. The yield is good and if they hold the divi then this has to be a buying opportunity.

[dr biotech] 12/11/2024 12:52

Pretty much a two year low. Guess having things made in china is not the place to be if there is going to be a trade war, although I think their sales in the US aren't that significant. This one is liable to jumpy price movements too.

[toffeeman] 12/11/2024 02:20

Chart seems to concur!

[toffeeman] 05/11/2024 00:46

I posted this on the wrong thread after watching the presentation:

Crikey what a downbeat outlook and presentation - even Europe which they think is the main opportunity.

[edmonda] 04/11/2024 15:53

Investor Presentation video recording (31 October 2024 webinar)

Andrew Gossage (CEO) & Chris Dent (CFO) of Ultimate Products plc hosted an Investor Presentation following the release of their results for the financial year to 31st July 2024.

They discussed their ambitions for European growth enhanced by their Paris showroom, countered by the the abating challenges of freight costs and UK consumer demand. Management provided a detailed run-though of financial performance figures, and answered a range of questions submitted by viewers.

The full video recording is available to watch, divided into chapters as below:
0:00:03 Introduction to Ultimate Products
0:07:50 Highlights of 2024
0:09:54 Products, Price, Brands, Capability
0:17:12 The opportunity in Europe
0:21:43 Financial Review
0:34:22 Summary & Outlook
0:40:43 Questions & Answers

Link to video recording:

[dr biotech] 29/10/2024 14:24

In track for 15p EPS next year, that would be decent and should lead to a modest re rating. Seems like a fairly solid company, nice that they actually say what the consensus forecast is too

[edmonda] 29/10/2024 07:25

"European growth prospects rise in importance"

Ultimate Products released FY2024 results which confirmed the company’s August trading statement at the sales, EBITDA pre-tax profits and EPS levels.

Detailed figures for sales by geographic region, brand, distribution channel and product category were published. Importantly, European sales advanced by 7%, moving to 34% of group sales from 30% in FY2023 as the company made significant advances with French and German discounters. This offset the negative impact of overstocking in the latter’s supermarket channels.

ULTP’s sales outlook for FY2025 is a return to growth. First, we expect a home market rebound as the company no longer faces the air fryers comparison issue. Second, there are clear signs that the Salter re-brand is working well and there will probably be some early benefits from a similar uplift for Beldray. Third, Europe should see further advances arising from the Paris showroom’s stronger sales into European discounters and more normal German supermarkets trading. However, the pattern of order flows suggests growth will pivot significantly towards the second half of the year.

We highlight UPs superior yield and attractive FY2025 0.8x EV/sales ratio. We continue to highlight potential for a material re-rating of the shares, driven partly by a return to positive sales momentum this year. We retain our 200p/share Fair Value.

Link to new research report:

[deanowls] 03/9/2024 07:14

Great, can I sell you some Vimto and would you like a kettle to boil it in, heres Jose who can arrange the finance of the deal. 😂

[edmonda] 03/9/2024 06:49

"New Board appointments support growth potential"

Strong relations with UK retailers and the potential to build on European expansion are important components of the value proposition and growth case for Ultimate Products plc.

The owner of the Beldray and Salter brands today announced two important Board appointments that are consistent with those objectives. As a brand manager with clearly prioritised distribution channels, we retain our 200p Fair Value for UP’s shares.

UP is to appoint two new Non-Executive Directors, both of which have pertinent experience and strong track records, to its Board with effect from 28th October this year. Andrew Milne, the current CEO of diversified and international soft drinks group Nichols plc, and José Carlos González-Hurtado, who holds Senior Advisor roles at global private equity firm Advent International and Roland Berger, an international management consultancy. We view these appointments positively.

Today’s announcement is consistent with UP’s growth strategy, which is driven by a twin commitment to its brands and distribution channels.

We reiterate the case for a 200p fair value, at which the company’s FY2025 EV/EBITDA would be 8.9x and its prospective P/E ratio an undemanding 13.8x.

Link to note:

[edmonda] 14/8/2024 06:48

UP says sales + EBITDA are in line with market expectations, with cautious optimism for the future. Versus peer consumer goods companies Equity Dev still think their rating is too low and keep a 200p Fair Value/share.

Read, hear summary of new ED research note below:

[deanowls] 13/6/2024 08:02

16.4 PE has it digitized the mops?